Greenwich Lifesciences Price To Book vs. Current Valuation
| GLSI Stock | USD 14.95 0.70 4.91% |
For Greenwich Lifesciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Greenwich Lifesciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Greenwich Lifesciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Greenwich Lifesciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Greenwich Lifesciences over time as well as its relative position and ranking within its peers.
Greenwich |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Greenwich Lifesciences Current Valuation vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Greenwich Lifesciences's current stock value. Our valuation model uses many indicators to compare Greenwich Lifesciences value to that of its competitors to determine the firm's financial worth. Greenwich Lifesciences is one of the top stocks in price to book category among its peers. It also is rated as one of the top companies in current valuation category among its peers reporting about 4,835,042 of Current Valuation per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Greenwich Lifesciences' earnings, one of the primary drivers of an investment's value.Greenwich Current Valuation vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Greenwich Lifesciences |
| = | 39.44 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Greenwich Lifesciences |
| = | 190.69 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Greenwich Current Valuation vs Competition
Greenwich Lifesciences is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 450.57 Million. Greenwich Lifesciences totals roughly 190.69 Million in current valuation claiming about 42% of equities under Health Care industry.
Greenwich Lifesciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Greenwich Lifesciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Greenwich Lifesciences will eventually generate negative long term returns. The profitability progress is the general direction of Greenwich Lifesciences' change in net profit over the period of time. It can combine multiple indicators of Greenwich Lifesciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -9.3 M | -8.9 M | |
| Net Loss | -8.9 M | -8.5 M | |
| Income Before Tax | -8.9 M | -8.4 M | |
| Net Loss | -4.1 M | -4.3 M | |
| Net Loss | -8.9 M | -8.4 M | |
| Total Other Income Expense Net | 436.1 K | 457.9 K | |
| Income Tax Expense | (2.00) | (2.10) | |
| Net Interest Income | 450.9 K | 473.5 K | |
| Interest Income | 450.9 K | 473.5 K | |
| Non Operating Income Net Other | 31.5 K | 33 K | |
| Change To Netincome | 759.7 K | 475.3 K | |
| Net Loss | (0.69) | (0.73) | |
| Income Quality | 0.73 | 0.38 | |
| Net Income Per E B T | 1.12 | 1.09 |
Greenwich Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Greenwich Lifesciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Greenwich Lifesciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Greenwich Lifesciences' important profitability drivers and their relationship over time.
Use Greenwich Lifesciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greenwich Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich Lifesciences will appreciate offsetting losses from the drop in the long position's value.Greenwich Lifesciences Pair Trading
Greenwich Lifesciences Pair Trading Analysis
The ability to find closely correlated positions to Greenwich Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greenwich Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greenwich Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greenwich Lifesciences to buy it.
The correlation of Greenwich Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greenwich Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greenwich Lifesciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greenwich Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Greenwich Lifesciences position
In addition to having Greenwich Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Advertising Thematic Idea Now
Advertising
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
To fully project Greenwich Lifesciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Greenwich Lifesciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Greenwich Lifesciences' income statement, its balance sheet, and the statement of cash flows.